微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-02-26 AccNo: 0001493152-18-002622 Size: 90 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits http...
$InspireMD Inc.(NSPR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-02-26 AccNo: 0001493152-18-002603 Size: 768 KB 网页链接
$InspireMD Inc.(NSPR)$ EFFECT - Notice of Effectiveness Filed: 2018-02-23 AccNo: 9999999995-18-000491 Size: 1 KB 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-02-22 AccNo: 0001493152-18-002490 Size: 61 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD Inc.(NSPR)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-02-21 AccNo: 0001493152-18-002474 Size: 501 KB 网页链接
$InspireMD Inc.(NSPR)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-02-21 AccNo: 0001493152-18-002474 Size: 501 KB 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-02-21 AccNo: 0001493152-18-002471 Size: 57 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-02-21 AccNo: 0001493152-18-002471 Size: 57 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-02-20 AccNo: 0001493152-18-002340 Size: 46 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InspireMD Inc.(NSPR)$ 8-K - Current report Filed: 2018-02-14 AccNo: 0001493152-18-002080 Size: 124 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接